Error message

No crossref credentials set for sci

Reversal of the TCR Stop Signal by CTLA-4

Science, 29 September 2006
Vol. 313, Issue 5795, p. 1972-1975
DOI: 10.1126/science.1131078

Reversal of the TCR Stop Signal by CTLA-4

  1. Helga Schneider1,2,
  2. Jos Downey1,
  3. Andrew Smith3,
  4. Bernd H. Zinselmeyer4,5,
  5. Catherine Rush4,5,
  6. James M. Brewer4,5,
  7. Bin Wei2,
  8. Nancy Hogg3,
  9. Paul Garside4,5,
  10. Christopher E. Rudd1,2,*
  1. 1 Cell Signalling Section, Division of Immunology, Department of Pathology, University of Cambridge, Cambridge CB2 1QP, UK.
  2. 2 Molecular Immunology Section, Department of Immunology, Division of Investigative Sciences, Imperial College London, London W12 ONN, UK.
  3. 3 Cancer Research UK London Research Institute, Lincoln's Inn Fields, London WC2A 3PX, UK.
  4. 4 Division of Immunology, Infection, and Inflammation, Western Infirmary, University of Glasgow, Glasgow G11 6NT, UK.
  5. 5 Centre for Biophotonics, University of Strathclyde, 27 Taylor Street, Glasgow G4 0NR, UK.
  1. * To whom correspondence should be addressed. E-mail: cer51{at}cam.ac.uk

Abstract

The coreceptor cytotoxic T lymphocyte–associated antigen 4 (CTLA-4) is pivotal in regulating the threshold of signals during T cell activation, although the underlying mechanism is still not fully understood. Using in vitro migration assays and in vivo two-photon laser scanning microscopy, we showed that CTLA-4 increases T cell motility and overrides the T cell receptor (TCR)–induced stop signal required for stable conjugate formation between T cells and antigen-presenting cells. This event led to reduced contact periods between T cells and antigen-presenting cells that in turn decreased cytokine production and proliferation. These results suggest a fundamentally different model of reverse stop signaling, by which CTLA-4 modulates the threshold for T cell activation and protects against autoimmunity.

  • Received for publication 9 June 2006.
  • Accepted for publication 1 August 2006.

Citation:

H. Schneider, J. Downey, A. Smith, B. H. Zinselmeyer, C. Rush, J. M. Brewer, B. Wei, N. Hogg, P. Garside, and C. E. Rudd, Reversal of the TCR Stop Signal by CTLA-4. Science 313, 1972-1975 (2006).

Individual Motile CD4+ T Cells Can Participate in Efficient Multikilling through Conjugation to Multiple Tumor Cells
I. Liadi, H. Singh, G. Romain, N. Rey-Villamizar, A. Merouane, J. R. T. Adolacion, P. Kebriaei, H. Huls, P. Qiu, B. Roysam et al.
Cancer Immunol Res 3, 473-482 (1 May 2015)

Immune Checkpoint Blockade in Cancer Therapy
M. A. Postow, M. K. Callahan, and J. D. Wolchok
JCO 0, JCO.2014.59.4358v1-JCO.2014.59.4358 (20 January 2015)

CD28-CD80 Interactions Control Regulatory T Cell Motility and Immunological Synapse Formation
T. J. Thauland, Y. Koguchi, M. L. Dustin, and D. C. Parker
J. Immunol. 193, 5894-5903 (15 December 2014)

The Immunological Synapse
M. L. Dustin, Y. Koguchi, M. L. Dustin, and D. C. Parker
Cancer Immunol Res 2, 1023-1033 (1 November 2014)

Cytotoxic T Lymphocyte Antigen-4 Blockade Enhances Antitumor Immunity by Stimulating Melanoma-Specific T-cell Motility
T. Pentcheva-Hoang, T. R. Simpson, W. Montalvo-Ortiz, and J. P. Allison
Cancer Immunol Res 2, 970-980 (1 October 2014)

Targeting Antigens through Blood Dendritic Cell Antigen 2 on Plasmacytoid Dendritic Cells Promotes Immunologic Tolerance
C. P. Chappell, N. V. Giltiay, K. E. Draves, C. Chen, M. S. Hayden-Ledbetter, M. J. Shlomchik, D. H. Kaplan, and E. A. Clark
J. Immunol. 192, 5789-5801 (15 June 2014)

Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival
S. D. Brown, R. L. Warren, E. A. Gibb, S. D. Martin, J. J. Spinelli, B. H. Nelson, and R. A. Holt
Genome Res 24, 743-750 (1 May 2014)

Differential Kinetics of Antigen Dependency of CD4+ and CD8+ T Cells
H. Rabenstein, A. C. Behrendt, J. W. Ellwart, R. Naumann, M. Horsch, J. Beckers, and R. Obst
J. Immunol. 192, 3507-3517 (15 April 2014)

Rab8 Binding to Immune Cell-Specific Adaptor LAX Facilitates Formation of trans-Golgi Network-Proximal CTLA-4 Vesicles for Surface Expression
M. C. Banton, K. L. Inder, E. Valk, C. E. Rudd, and H. Schneider
Mol. Cell. Biol. 34, 1486-1499 (15 April 2014)

Cytotoxic-T-Lymphocyte Antigen 4 Receptor Signaling for Lymphocyte Adhesion Is Mediated by C3G and Rap1
Y. Kloog, and A. Mor
Mol. Cell. Biol. 34, 978-988 (15 March 2014)

Real-time immune cell interactions in target tissue during autoimmune-induced damage and graft tolerance
J. Miska, M. H. Abdulreda, P. Devarajan, J. B. Lui, J. Suzuki, A. Pileggi, P.-O. Berggren, and Z. Chen
JEM 211, 441-456 (10 March 2014)

T-cell Receptor (TCR)-Peptide Specificity Overrides Affinity-enhancing TCR-Major Histocompatibility Complex Interactions
D. K. Cole, K. M. Miles, F. Madura, C. J. Holland, A. J. A. Schauenburg, A. J. Godkin, A. M. Bulek, A. Fuller, H. J. E. Akpovwa, P. G. Pymm et al.
J Biol Chem 289, 628-638 (10 January 2014)

Exploiting Apoptosis for Therapeutic Tolerance Induction
D. R. Getts, D. P. McCarthy, and S. D. Miller
J. Immunol. 191, 5341-5346 (1 December 2013)

Controlled Local Delivery of CTLA-4 Blocking Antibody Induces CD8+ T-Cell-Dependent Tumor Eradication and Decreases Risk of Toxic Side Effects
M. F. Fransen, T. C. van der Sluis, F. Ossendorp, R. Arens, and C. J. M. Melief
Clin. Cancer Res. 19, 5381-5389 (1 October 2013)

CTLA-4 and PD-1/PD-L1 Blockade: New Immunotherapeutic Modalities with Durable Clinical Benefit in Melanoma Patients
P. A. Ott, F. S. Hodi, and C. Robert
Clin. Cancer Res. 19, 5300-5309 (1 October 2013)

CD28 Sensitizes TCR Ca2+ Signaling during Ag-Independent Polarization of Plasma Membrane Rafts
J. N. Byrum, J. S. Van Komen, and W. Rodgers
J. Immunol. 191, 3073-3081 (15 September 2013)

Multistage T Cell-Dendritic Cell Interactions Control Optimal CD4 T Cell Activation through the ADAP-SKAP55-Signaling Module
J. S. Mitchell, B. J. Burbach, R. Srivastava, B. T. Fife, and Y. Shimizu
J. Immunol. 191, 2372-2383 (1 September 2013)

At the Bench: Preclinical rationale for CTLA-4 and PD-1 blockade as cancer immunotherapy
A. M. Intlekofer, and C. B. Thompson
J. Leukoc. Biol. 94, 25-39 (1 July 2013)

Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4
R. B. Holmgaard, D. Zamarin, D. H. Munn, J. D. Wolchok, and J. P. Allison
JEM 210, 1389-1402 (25 June 2013)

Construction of self-recognizing regulatory T cells from conventional T cells by controlling CTLA-4 and IL-2 expression
T. Yamaguchi, A. Kishi, M. Osaki, H. Morikawa, P. Prieto-Martin, K. Wing, T. Saito, and S. Sakaguchi
Proc. Natl. Acad. Sci. USA 110, E2116-E2125 (4 June 2013)

Structure and Interactions of the Human Programmed Cell Death 1 Receptor
X. Cheng, V. Veverka, A. Radhakrishnan, L. C. Waters, F. W. Muskett, S. H. Morgan, J. Huo, C. Yu, E. J. Evans, A. J. Leslie et al.
J Biol Chem 288, 11771-11785 (26 April 2013)

PD-1 promotes immune exhaustion by inducing antiviral T cell motility paralysis
B. H. Zinselmeyer, S. Heydari, C. Sacristan, D. Nayak, M. Cammer, J. Herz, X. Cheng, S. J. Davis, M. L. Dustin, D. B. McGavern et al.
JEM 210, 757-774 (8 April 2013)

CTLA-4 blockade in tumor models: an overview of preclinical and translational research
J. F. Grosso, and M. N. Jure-Kunkel
Cancer Immun 13, 5-5 (1 January 2013)

Murine regulatory T cells differ from conventional T cells in resisting the CTLA-4 reversal of TCR stop-signal
Y. Lu, H. Schneider, and C. E. Rudd
Blood 120, 4560-4570 (29 November 2012)

How recent advances in immunotherapy are changing the standard of care for patients with metastatic melanoma
J. Wolchok, H. Schneider, and C. E. Rudd
Ann Oncol 23, viii15-viii21 (1 September 2012)

New Anticancer Immunotherapies
H. A. FRANKS, Q. WANG, and P. M. PATEL
Anticancer Res 32, 2439-2453 (1 July 2012)

A Decade of Imaging Cellular Motility and Interaction Dynamics in the Immune System
R. N. Germain, E. A. Robey, and M. D. Cahalan
Science 336, 1676-1681 (29 June 2012)

Opposing roles for RhoH GTPase during T-cell migration and activation
C. M. Baker, W. A. Comrie, Y.-M. Hyun, H.-L. Chung, C. A. Fedorchuk, K. Lim, C. Brakebusch, J. L. McGrath, R. E. Waugh, M. Meier-Schellersheim et al.
Proc. Natl. Acad. Sci. USA 109, 10474-10479 (26 June 2012)

Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2
T. Yokosuka, M. Takamatsu, W. Kobayashi-Imanishi, A. Hashimoto-Tane, M. Azuma, and T. Saito
JEM 209, 1201-1217 (4 June 2012)

Suppression of Antigen-Specific T Cell Responses by the Kaposi's Sarcoma-Associated Herpesvirus Viral OX2 Protein and Its Cellular Orthologue, CD200
K. Misstear, S. A. Chanas, S. A. R. Rezaee, R. Colman, L. L. Quinn, H. M. Long, O. Goodyear, J. M. Lord, A. D. Hislop, D. J. Blackbourn et al.
J. Virol. 86, 6246-6257 (1 June 2012)

Basis of CTLA-4 function in regulatory and conventional CD4+ T cells
X. Tai, F. Van Laethem, L. Pobezinsky, T. Guinter, S. O. Sharrow, A. Adams, L. Granger, M. Kruhlak, T. Lindsten, C. B. Thompson et al.
Blood 119, 5155-5163 (31 May 2012)

A novel method to allow noninvasive, longitudinal imaging of the murine immune system in vivo
V. B. Gibson, R. A. Benson, K. J. Bryson, I. B. McInnes, C. M. Rush, G. Grassia, P. Maffia, E. J. Jenkinson, A. J. White, G. Anderson et al.
Blood 119, 2545-2551 (15 March 2012)

Immunotherapy earns its spot in the ranks of cancer therapy
D. Pardoll, and C. Drake
JEM 209, 201-209 (13 February 2012)

Cross-Talk Between TCR and CCR7 Signaling Sets a Temporal Threshold for Enhanced T Lymphocyte Migration
K. Schaeuble, M. A. Hauser, E. Singer, M. Groettrup, and D. F. Legler
J. Immunol. 187, 5645-5652 (1 December 2011)

A Live Imaging Cell Motility Screen Identifies Prostaglandin E2 as a T Cell Stop Signal Antagonist
A. J. Wiemer, S. Hegde, J. E. Gumperz, and A. Huttenlocher
J. Immunol. 187, 3663-3670 (1 October 2011)

Cytotoxic T-Lymphocyte-Associated Antigen-4
A. K. S. Salama, and F. S. Hodi
Clin. Cancer Res. 17, 4622-4628 (15 July 2011)

The Soluble CTLA-4 Splice Variant Protects From Type 1 Diabetes and Potentiates Regulatory T-Cell Function
K. D. Gerold, P. Zheng, D. B. Rainbow, A. Zernecke, L. S. Wicker, and S. Kissler
Diabetes 60, 1955-1963 (1 July 2011)

CTLA4 Blockade Induces Frequent Tumor Infiltration by Activated Lymphocytes Regardless of Clinical Responses in Humans
R. R. Huang, J. Jalil, J. S. Economou, B. Chmielowski, R. C. Koya, S. Mok, H. Sazegar, E. Seja, A. Villanueva, J. Gomez-Navarro et al.
Clin. Cancer Res. 17, 4101-4109 (15 June 2011)

LFA-1 activity state on dendritic cells regulates contact duration with T cells and promotes T-cell priming
S. Balkow, S. Heinz, P. Schmidbauer, W. Kolanus, B. Holzmann, S. Grabbe, and M. Laschinger
Blood 116, 1885-1894 (16 September 2010)

Dendritic Cell-Directed CTLA-4 Engagement during Pancreatic {beta} Cell Antigen Presentation Delays Type 1 Diabetes
S. Karumuthil-Melethil, N. Perez, R. Li, B. S. Prabhakar, M. J. Holterman, and C. Vasu
J. Immunol. 184, 6695-6708 (15 June 2010)

Inducing CTLA-4-Dependent Immune Regulation by Selective CD28 Blockade Promotes Regulatory T Cells in Organ Transplantation
N. Poirier, A. M. Azimzadeh, T. Zhang, N. Dilek, C. Mary, B. Nguyen, X. Tillou, G. Wu, K. Reneaudin, J. Hervouet et al.
Sci Transl Med 2, 17ra10-17ra10 (3 February 2010)

Dual function of CTLA-4 in regulatory T cells and conventional T cells to prevent multiorgan autoimmunity
N. Jain, H. Nguyen, C. Chambers, and J. Kang
Proc. Natl. Acad. Sci. USA 107, 1524-1528 (26 January 2010)

Dendritic Cell Vaccination Combined with CTLA4 Blockade in Patients with Metastatic Melanoma
A. Ribas, B. Comin-Anduix, B. Chmielowski, J. Jalil, P. de la Rocha, T. A. McCannel, M. T. Ochoa, E. Seja, A. Villanueva, D. K. Oseguera et al.
Clin. Cancer Res. 15, 6267-6276 (1 October 2009)

SLP-76-ADAP adaptor module regulates LFA-1 mediated costimulation and T cell motility
H. Wang, B. Wei, G. Bismuth, and C. E. Rudd
Proc. Natl. Acad. Sci. USA 106, 12436-12441 (28 July 2009)

PD-1 and CTLA-4 Inhibitory Cosignaling Pathways in HIV Infection and the Potential for Therapeutic Intervention
D. E. Kaufmann, and B. D. Walker
J. Immunol. 182, 5891-5897 (15 May 2009)

CTLA-4 on alloreactive CD4 T cells interacts with recipient CD80/86 to promote tolerance
J. Kurtz, F. Raval, C. Vallot, J. Der, and M. Sykes
Blood 113, 3475-3484 (9 April 2009)

Enhanced selection of FoxP3+ T-regulatory cells protects CTLA-4-deficient mice from CNS autoimmune disease
J. Verhagen, L. Gabrysova, S. Minaee, C. A. Sabatos, G. Anderson, A. H. Sharpe, and D. C. Wraith
Proc. Natl. Acad. Sci. USA 106, 3306-3311 (3 March 2009)

CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance
R. H. Friedline, D. S. Brown, H. Nguyen, H. Kornfeld, J. Lee, Y. Zhang, M. Appleby, S. D. Der, J. Kang, C. A. Chambers et al.
JEM 206, 421-434 (16 February 2009)

Mechanisms of chemokine and antigen-dependent T-lymphocyte navigation
S. G. Ward, and F. M. Marelli-Berg
Biochem. J. 418, 13-27 (15 February 2009)

Intratumoral Immune Cell Infiltrates, FoxP3, and Indoleamine 2,3-Dioxygenase in Patients with Melanoma Undergoing CTLA4 Blockade
A. Ribas, B. Comin-Anduix, J. S. Economou, T. R. Donahue, P. de la Rocha, L. F. Morris, J. Jalil, V. B. Dissette, I. P. Shintaku, J. A. Glaspy et al.
Clin. Cancer Res. 15, 390-399 (1 January 2009)

CTLA-4 Controls Regulatory T Cell Peripheral Homeostasis and Is Required for Suppression of Pancreatic Islet Autoimmunity
E. M. Schmidt, C. J. Wang, G. A. Ryan, L. E. Clough, O. S. Qureshi, M. Goodall, A. K. Abbas, A. H. Sharpe, D. M. Sansom, L. S. K. Walker et al.
J. Immunol. 182, 274-282 (1 January 2009)

Protection from graft-versus-host disease with a novel B7 binding site-specific mouse anti-mouse CD28 monoclonal antibody
N. Beyersdorf, X. Ding, G. Blank, K. M. Dennehy, T. Kerkau, and T. Hunig
Blood 112, 4328-4336 (15 November 2008)

p21 Ras/Impedes Mitogenic Signal Propagation Regulates Cytokine Production and Migration in CD4 T Cells
J. Czyzyk, H.-C. Chen, K. Bottomly, and R. A. Flavell
J Biol Chem 283, 23004-23015 (22 August 2008)

Targeted Therapies to Improve Tumor Immunotherapy
J. Begley, and A. Ribas
Clin. Cancer Res. 14, 4385-4391 (15 July 2008)

How Antigen Quantity and Quality Determine T-Cell Decisions in Lymphoid Tissue
H. Zheng, B. Jin, S. E. Henrickson, A. S. Perelson, U. H. von Andrian, and A. K. Chakraborty
Mol. Cell. Biol. 28, 4040-4051 (15 June 2008)

IFN-{gamma} and STAT1 Arrest Monocyte Migration and Modulate RAC/CDC42 Pathways
Y. Hu, X. Hu, L. Boumsell, and L. B. Ivashkiv
J. Immunol. 180, 8057-8065 (15 June 2008)

Enhanced Engagement of CTLA-4 Induces Antigen-Specific CD4+CD25+Foxp3+ and CD4+CD25- TGF-{beta}1+ Adaptive Regulatory T Cells
R. Li, N. Perez, S. Karumuthil-Melethil, B. S. Prabhakar, M. J. Holterman, and C. Vasu
J. Immunol. 179, 5191-5203 (15 October 2007)

The PP2A-associated Protein {alpha}4 Plays a Critical Role in the Regulation of Cell Spreading and Migration
M. Kong, T. V. Bui, D. Ditsworth, J. J. Gruber, D. Goncharov, V. P. Krymskaya, T. Lindsten, and C. B. Thompson
J Biol Chem 282, 29712-29720 (5 October 2007)

CTLA-4 and CD4+CD25+ Regulatory T Cells Inhibit Protective Immunity to Filarial Parasites In Vivo
M. D. Taylor, A. Harris, S. A. Babayan, O. Bain, A. Culshaw, J. E. Allen, and R. M. Maizels
J. Immunol. 179, 4626-4634 (1 October 2007)

Cytotoxic T-Lymphocyte-Associated Antigen-4
F. S. Hodi, A. Harris, S. A. Babayan, O. Bain, A. Culshaw, J. E. Allen, and R. M. Maizels
Clin. Cancer Res. 13, 5238-5242 (15 September 2007)

CTL-Associated Antigen-4 Ligation Induces Rapid T Cell Polarization That Depends on Phosphatidylinositol 3-Kinase, Vav-1, Cdc42, and Myosin Light Chain Kinase
B. Wei, S. da Rocha Dias, H. Wang, and C. E. Rudd
J. Immunol. 179, 400-408 (1 July 2007)

Immunology. Restless T cells sniff and go.
T. Mustelin, S. da Rocha Dias, H. Wang, and C. E. Rudd
Science 313, 1902-1903 (29 September 2006)

T cells told to keep rolling
N. LeBrasseur, S. da Rocha Dias, H. Wang, and C. E. Rudd
JCB 174, 909a-909a (25 September 2006)

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882